Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Other Operating Expenses (2023 - 2025)

Krystal Biotech's Other Operating Expenses history spans 4 years, with the latest figure at $6.4 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 117.13% year-over-year to $6.4 million; the TTM value through Dec 2025 reached $23.0 million, up 202.95%, while the annual FY2024 figure was -$37.5 million, 137.5% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $6.4 million at Krystal Biotech, up from $4.4 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $7.2 million in Q2 2025 and bottomed at -$37.5 million in Q4 2024.
  • The 4-year median for Other Operating Expenses is $4.4 million (2025), against an average of -$1.1 million.
  • The largest annual shift saw Other Operating Expenses soared 2884.38% in 2024 before it crashed 33.7% in 2025.
  • A 4-year view of Other Operating Expenses shows it stood at $1000.0 in 2021, then surged by 22300.0% to $224000.0 in 2023, then plummeted by 16841.07% to -$37.5 million in 2024, then skyrocketed by 117.13% to $6.4 million in 2025.
  • Per Business Quant, the three most recent readings for KRYS's Other Operating Expenses are $6.4 million (Q4 2025), $4.4 million (Q3 2025), and $7.2 million (Q2 2025).